What is the debt of Cosmos Pharmaceutical this year?
Cosmos Pharmaceutical has a debt level of -27,727 JPY this year.
In 2024, Cosmos Pharmaceutical's total debt was -27,727 JPY, a -0.79% change from the -27,949 JPY total debt recorded in the previous year.
Cosmos Pharmaceutical's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Analyzing Cosmos Pharmaceutical's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Investors pay close attention to Cosmos Pharmaceutical’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Shifts in Cosmos Pharmaceutical’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Cosmos Pharmaceutical has a debt level of -27,727 JPY this year.
The debt of Cosmos Pharmaceutical has increased by -0.79% compared to the previous year dropped.
High debt can pose a risk for investors of Cosmos Pharmaceutical, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
Low debt means that Cosmos Pharmaceutical has a strong financial position and is able to fulfill its obligations without overburdening its finances.
An increase in debt of Cosmos Pharmaceutical can adversely affect the financial condition of the company and result in a higher burden on its finances.
A reduction in debt of Cosmos Pharmaceutical can strengthen the company's financial position and improve its ability to meet its financial obligations.
Some factors that can influence the debt of Cosmos Pharmaceutical include investments, acquisitions, operating costs, and revenue development.
The debts of Cosmos Pharmaceutical are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
To change the debt, Cosmos Pharmaceutical can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
Over the past 12 months, Cosmos Pharmaceutical paid a dividend of 117.5 JPY . This corresponds to a dividend yield of about 0.91 %. For the coming 12 months, Cosmos Pharmaceutical is expected to pay a dividend of 129.92 JPY.
The current dividend yield of Cosmos Pharmaceutical is 0.91 %.
Cosmos Pharmaceutical pays a quarterly dividend. This is distributed in the months of December, June, December, June.
Cosmos Pharmaceutical paid dividends every year for the past 22 years.
For the upcoming 12 months, dividends amounting to 129.92 JPY are expected. This corresponds to a dividend yield of 1 %.
Cosmos Pharmaceutical is assigned to the 'Non-cyclical consumption' sector.
To receive the latest dividend of Cosmos Pharmaceutical from 8/1/2024 amounting to 60 JPY, you needed to have the stock in your portfolio before the ex-date on 5/30/2024.
The last dividend was paid out on 8/1/2024.
In the year 2023, Cosmos Pharmaceutical distributed 82.5 JPY as dividends.
The dividends of Cosmos Pharmaceutical are distributed in JPY.
Our stock analysis for Cosmos Pharmaceutical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cosmos Pharmaceutical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.